Noroviruses are the main causative agents of acute viral gastroenteritis worldwide. However, no vaccine or specific antiviral treatment is available, imposing a heavy global health burden. The nucleoside analogue 2’-fluoro-2’-deoxycytidine (2’-FdC) has been reported to have broad antiviral activity. Here, we report that 2’-FdC significantly inhibits murine norovirus replication in macrophages. This effect was partially reversed by exogenous supplementation of cytidine triphosphate. The combination of 2’-FdC with mycophenolic acid, ribavirin or favipiravir (T705) exerts synergistic antiviral effects. These results indicate that 2’-FdC is a potential candidate for antiviral drug development against norovirus infection.

Additional Metadata
Persistent URL dx.doi.org/10.1007/s00705-020-04759-4, hdl.handle.net/1765/129526
Journal Archives of Virology
Citation
Yu, P. (Peifa), Wang, Y. (Yining), Li, Y. (Yunlong), Li, Y. (Yang), Miao, Z. (Zhijiang), Peppelenbosch, M.P, & Pan, Q. (2020). 2’-Fluoro-2’-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705. Archives of Virology. doi:10.1007/s00705-020-04759-4